CareDx Inc Stock Statistic Functions Standard Deviation
| CDNA Stock | USD 17.02 0.57 3.47% |
| Symbol |
CareDx Technical Analysis Modules
Most technical analysis of CareDx help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for CareDx from various momentum indicators to cycle indicators. When you analyze CareDx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
Methodology
Unless otherwise specified, financial data for CareDx Inc is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. CareDx (USA Stocks:CDNA) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Information for CareDx Inc is compiled from public filings and market reference sources and official sources including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Reporting latency may occur in some cases. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
CareDx Inc is covered by 8 analysts. 4 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include J.P. Morgan, Guggenheim Securities, Bank of America Securities, Oppenheimer & Co., Evercore ISI, Goldman Sachs, Deutsche Bank, among others. Updates may occur throughout the day.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial BoardAlign your values with your investing style
Thematic Opportunities
Explore Investment Opportunities
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | SRI Sustainable Growth Invested few shares | |
 | Baby Boomer Prospects Invested over 20 shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Investor Favorites Invested few shares | |
 | Blockchain Invested few shares | |
 | Advertising Invested few shares | |
 | Cash Cows Invested few shares | |
 | Driverless Cars Invested few shares | |
 | Impulse Invested over 200 shares | |
 | Hedge Favorites Invested few shares | |
 | Adviser Favorites Invested few shares | |
 | Warren Buffett Holdings Invested over 20 shares | |
 | Macroaxis Picks Invested few shares |
More Resources for CareDx Stock Analysis
A comprehensive view of CareDx Inc starts with financial statements and ratio context. Financial ratios provide context for profitability, efficiency, and growth trends. Outlined below are key reports that provide context for CareDx Inc Stock: Earnings Share -0.40 | Revenue Per Share | Quarterly Revenue Growth 0.252 | Return On Assets | Return On Equity |